BCL2 and colorectal cancer: Other researchers have reported similar findings in differing groups of colorectal cancer patients [4,5], with the p53(-)/Bcl-2(+) subset appearing to define a group of patients who appear to have a prolonged survival, although this has not always retained independence on multivariate analysis [6,7].